Resource Center
Latest Publications
System-Based Calculations Miss Key Details in Gov’t Pricing
System-based calculations miss crucial details in government price reporting.When you have complete visibility into the process driving your government pricing computations, you have control. You gain certainty and confidence knowing your monthly and quarterly...
Trust the Data Behind Government Pricing Computations
Have confidence in the data that drives government pricing computations.Missed transaction-level details can skew government pricing computations and impact your bottom line by millions of dollars. That’s why it is imperative to have confidence in the data that drives...
Why Medicaid Is Pharma’s Most Demanding Government Program
Why Medicaid is a pharma company’s most demanding government program in terms of potential impact and resources.For both brand and generic pharma companies, the most demanding of the government programs, in terms of financial impact and required resources, is often...
Avoiding Costly Government Pricing Mistakes
Avoiding Costly Government Pricing MistakesBasic steps pharmaceutical manufacturers should employ to avoid erroneous government pricing calculationsManaging Government Pricing (GP) computations can feel a bit like walking through a cave without a flashlight. Even an...
Emerging Drug Price Disclosure Legislation – Jan 2020
Continued Emergence of Drug Price Disclosure Legislation Tips for staying compliant with an accelerating trend The summer of 2019 saw an 86 percent increase in the number of states enacting pharmaceutical drug price disclosure laws. This paper, our second in a series...
Drug Price Disclosure Legislation – April 2019
Drug Price Disclosure LegislationFour steps to staying ahead and staying compliantMany states have moved to enact mandatory pharmaceutical price disclosure laws that would increase price transparency to address prescription drug costs (Fig. 1, pg. 3). In 2018, states...